SUMMARY Twenty one patients with retained endocardial pacemaker leads were followed during a total observation period of 1097 months to assess the incidence of complications. Two patients developed thrombosis and occlusion of the superior vena cava, which was relieved by the development of a collateral venous circulation. In one patient the broken tip of the lead migrated to a pulmonary artery but did not cause overt complications. The remaining patients were free of symptoms. One patient died for reasons unconnected with pacemaker treatment.
Complications of pacemaker treatment such as infection, lead fracture, insulation break, threshold increase (especially with non-programmable pacemakers), and electrode displacement may need corrective surgery to insert a new pacing lead. Removal of primary, now functionless and often defective, leads cannot always be achieved. As a result, there are two or sometimes even more leads in the cardiovascular system, which increases the risk of thrombus formation, infection, or migration of the lead. To assess this risk we studied patients with retained pacing leads.
Patients, methods, and results
The clinical records of permanent pacemaker implantations from January 1972 Both functionless electrodes remained in the cardiovascular system despite attempts to remove them; Funcionless retained pacing lads in the cadiovasaclar ystem the first lead migrated into the right internal jugular vein (Fig 1) .
Case 2-An EMT 588 lead was inserted in August 1972 in a 60 year old man because of complete atrioventricular block. The lead became dislodged two months later; repositioning and removal were impossible, and a second EMT 588 lead was implanted. In May 1983 a third lead was introduced because of late infection of the pacemaker pocket three months after replacement (Fig. 2) .
Case 3-A 54 year old man underwent implantation of the LEM lead for intermittent second degree atrioventricular block in March 1976. Pacing ceased in September 1982 because of a threshold increase. During attempted withdrawal the lead broke leaving the tip in the heart. Subsequently, the electrode migrated into one of the proximal branches of the right pulmonary artery without producing any clinical symptoms and signs either immediately after the event or later during 21 months follow up (Fig. 3) .
FOLLOW UP AND OUTCOME All the patients were followed up to the end of June 1984. The total observation period for patients with two pacing leads was 1097 (range 16-127) months. Mean observation time was 52-2 (median 37) months. Two patients with three leads were followed for 11 and 22 months after the insertion of a third lead.
In two patients, previously reported major venous thrombosis occurred 11 and 24 months after insertion of a new pacing lead.' In both cases symptoms and signs of thrombosis and occlusion of the superior vena cava were relieved by the development of collateral 
